TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/16/24 16:34 | 1/5/24 | ATHA | Athira Pharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Gengos Andrew | WA | O | CFO,CHIE | S.a | -4 | 2.91 | 0 | -1 | -1 | 84 | D | |||||||||||||||
1/8/24 16:42 | 1/5/23 | ATHA | Athira Pharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Gengos Andrew | WA | O | See Belo | S | -4 | 2.91 | 0 | -1 | -1 | 84 | D | |||||||||||||||
6/9/23 17:06 | 6/7/23 | ATHA | Athira Pharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Gengos Andrew | WA | O | See Belo | P | 51 | 3.43 | 0 | 15 | 23 | 80 | D | |||||||||||||||
6/6/23 19:36 | 6/2/23 | ATHA | Athira Pharma, Inc. | Health | BioPrd | Biological Products, (No Diag | Gengos Andrew | WA | O | See Belo | P.m | 192 | 2.95 | 0 | 65 | New | 65 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |